51成人动漫

Crystal Phend

Crystal Phend

Authors >

Crystal Phend

Crystal Phend is a contributing editor with 51成人动漫, where she's been covering medical news of all stripes since 2006.

Connect:

email image

Latest from Crystal Phend

ESC over a computer rendering of the human heart and an electrocardiogram

'Definitive Data': Continuing ACE/ARB Tx Safe in COVID-19

Randomized trial affirms no harm in mild to moderate coronavirus cases

ESC over a computer rendering of the human heart and an electrocardiogram

Colchicine Scores for CV Secondary Prevention

LoDoCo2 trial finds substantial benefit, but questions linger

ESC over a computer rendering of the human heart and an electrocardiogram

SGLT2 Inhibitor Wows in Chronic Kidney Disease

DAPA-CKD shows fewer renal events, prolonged overall survival

ESC over a computer rendering of the human heart and an electrocardiogram

Low-Dose DOAC Valuable in Afib After Age 80

Randomized trial suggests benefit on par with warfarin in younger groups

ESC over a computer rendering of the human heart and an electrocardiogram

Second SGLT2 Drug Scores for HFrEF, Regardless of Diabetes Status

EMPEROR-Reduced trial "exceptionally concordant" with DAPA-HF results

Cardiac magnetic resonance imaging technologists observe a patient during a cardiac MRI scan

Post-COVID Heart Problems Are Real, Despite Study Corrections

Conclusions still stand, group says after fixing a raft of data errors

A computer rendering of coronaviruses in the heart

Smoking Gun Found for Virus in MIS-C Heart Damage Case

First case report documenting viral particles in the heart in MIS-C

A glucose meter and a pile of various pills

Diabetes Drugs Looking for Broad Role in COVID-19

The mechanisms check out and trials are underway

A blue gloved hand holds a test tube labeled: Lupus anticoagulant (LA) - Test

Lupus Anticoagulant Tied to COVID Thrombosis

Small study suggests consideration of therapeutic anticoagulation

A patient in a hospital ICU receives extracorporeal membrane oxygenation

ECMO Gets a Win in Severe COVID-19

High success rate seen at two Chicago centers counters early reports

鈥�

42